Aberrant expression of GPR37 was also implicated in several cancers, including gastric cancer, multiple myeloma, and hepatocellular carcinoma [38–41], yet little is known of its involvement in breast cancer. This evidence concerns the gene GPR37 and plasma cell myeloma.